Publication | Closed Access

Inhibition of Epstein–Barr virus early antigen activation promoted by 12-O-tetradecanoylphorbol-13-acetate by the non-steroidal anti-inflammatory drugs

MedicineImmunologyTumor ImmunityImmune RegulationAntiviral TherapyAntiviral ResponseHumoral ImmunityPharmacotherapyImmunotherapeuticsNon-steroidal Anti-inflammatory DrugsPharmacologyViral OncologyEarly Antigen Activation